admin – Page 4118 – Get News Story

Financh Launches Private Company Financial Database and Company Financial Reports, Delivering Unmatched Business Intelligence Across All 50 U.S. States

““Accurate, real-time business intelligence is essential in today’s complex market. Our private company financial database and company financial reports ensure that businesses across the United States have access to unparalleled insights, helping them make data-driven decisions with confidence,” said MD Sadique Akhter, CEO and President of Financh.”

Financh has introduced a comprehensive private company financial database and company financial reports across all 50 U.S. states. This launch enhances business intelligence, offering deep insights into company profiles, M&A activity, venture capital trends, and corporate compliance checks, providing critical data for investors and businesses alike.

New York, USA – Financh, a global leader in market intelligence and private company data, has announced the launch of its cutting-edge private company financial database and company financial reports covering all 50 U.S. states. This initiative aims to revolutionize business intelligence, providing access to critical data points, including financial performance tracking, funding activity reports, venture capital database insights, and corporate compliance checks.

In today’s rapidly evolving economic landscape, businesses, investors, and financial analysts require timely and comprehensive data to make informed decisions. Financh’s latest offering delivers extensive company profiles and analysis, allowing users to track key financial metrics, conduct competitor analysis, and navigate M&A activity across the United States.

Empowering Decision-Makers with Data-Driven Insights

The newly launched private company financial database equips professionals with detailed financial reports, including income statements, balance sheets, and cash flow analyses. These reports provide critical insights into private company data, enabling venture capitalists, private equity firms, and investment banks to identify lucrative opportunities and mitigate risks.

Comprehensive Coverage Across 50 States

Financh’s database spans all 50 states, offering industry insights and competitive benchmarking for companies of all sizes. The platform allows users to track funding and investment data, monitor M&A transactions through its M&A database, and gain visibility into private equity trends in the U.S. market.

This launch further cements Financh’s position as a trusted resource for corporate compliance checks, investor profiles, and startup directories. The platform’s extensive data coverage makes it an invaluable tool for businesses seeking competitive advantages in their respective industries.

Advancing M&A and Venture Capital Trends

With an increasing demand for precise financial data, Financh’s venture capital database provides real-time tracking of funding rounds, deal-sourcing tools, and insights into emerging market trends. The M&A database enables companies to evaluate acquisitions, identify strategic partners, and forecast deal activity with greater accuracy.

“Our goal is to redefine how financial professionals access and utilize data,” added Sadique. “By providing reliable private company financial data, we are enabling businesses to track company performance, benchmark against competitors, and uncover new investment opportunities.”

Driving Transparency and Corporate Compliance

Financh’s commitment to transparency extends to its corporate compliance checks, ensuring users can verify business credibility and regulatory adherence. The database helps businesses conduct thorough due diligence, minimizing risks associated with private company investments and transactions.

The platform also integrates funding activity reports, allowing investors to assess market dynamics, track private equity investments, and gain a comprehensive understanding of venture capital trends across the United States.

About Financh

Financh is a leading provider of global market intelligence and private company data. With partnerships spanning 185 countries, Financh delivers insights on over 400 million companies across 250 industries. The company’s platform offers robust financial analytics, including company financial reports, M&A transaction insights, and competitive benchmarking tools. By providing real-time access to venture capital trends, private equity data, and startup directories, Financh empowers businesses to make informed strategic decisions. With a focus on innovation and data accuracy, Financh continues to redefine global business intelligence. Read more about Financh here https://financh.org

Media Contact
Company Name: Financh
Contact Person: Press Team
Email: Send Email
Address:447 Broadway, 1137, 2nd Floor
State: New York
Country: United States
Website: https://financh.org/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Financh Launches Private Company Financial Database and Company Financial Reports, Delivering Unmatched Business Intelligence Across All 50 U.S. States

Breaking Free: Frank Rahmaan’s “The Wilted Black Rose” Explores Resilience and Redemption

A Moving Memoir of Healing and Transformation, “The Wilted Black Rose” shares Frank Rahmaan’s personal journey of overcoming multi-generational trauma and finding hope in the face of adversity.

Prepare to embark on a transformative journey with Frank Rahmaan’s compelling new book, The Wilted Black Rose: Breaking Free from Multi-Generational Trauma.

This stirring memoir and self-help guide tells the tale of resilience, healing, and redemption in the streets of Oakland, bittersweet in life but rich in experience. The well promises to go deep into the guts of readers who are on their trails to recovery and self-discovery.

A Personal Journey of Survival and Transformation

More than that, Rahmaan’s story is a testimony to the most voluminous challenges that the human spirit overcomes. In the face of acute realities of multi-generational trauma and many more jigsaw pieces that shape lives over generations, born and raised in Oakland, California, he exposes it with daring, which brings him nearer to reality.

The readers are invited to experience the punch of a narrative family saga, love-an-word-struggle-triumph relations. Rahmaan recounted the extreme fire of desperation within his father and the unshakable commitment of his mother, as well as his long path of healing from his uncle’s legacies, which are full of turbulence.

Empowering Readers Through the Art of Healing

At its core, The Wilted Black Rose is more than a memoir; it’s a guide to reclaiming power and finding light in the darkest moments. Personal experiences with practical approaches to trauma recovery provide Rahmaan an optimal way of weaving stories into these chapters.

Recognizing What Affects Me, Finding Light in the Darkness, and Becoming Your Own Advocate will shine like beacons of hope for anyone who feels they have been imprisoned by the past.

Rahmaan throws open the vista, writes poetry in the air, and practically approaches the psychology of trauma; this illustration he will give of how one may dismantle inherited cycles of pain. His words are thus a clarion call to action-to not just survive but thrive.

Critical Acclaim for The Wilted Black Rose

The Wilted Black Rose has been commended by reviewers and readers alike for its moving narrative and realistic advice in life:

“Rahmaan’s voice is both authentic and transformational. This book is a lifeline for those seeking to heal from trauma.” — Literary Beacon Review.

“Goes very deep into resilience and hope, and Frank Rahmaan’s is one story you’d carry long after you finished the last page.” — The Self-Help Journal.

“A raw and deeply human exploration of trauma and redemption. The Wilted Black Rose is a masterpiece of personal growth.” — Reader’s Haven.

A Voice for the Unseen and Unheard

As a survivor and an advocate, he is trying to inspire others to face their struggles and empower themselves. His words ring true for anyone who has ever felt invisible, unheard, or trapped in circumstances of life’s making. Rahmaan reminds us of community, understanding, and perseverance in his story.

Explore Tools for Lasting Transformation

In addition to sharing his personal journey, Rahmaan offers practical exercises that enable readers to take charge of their healing journey. In fact, there is a special section in the book called Healing Journal, where readers can find prompts like Creating a Safe Place, Turning Pain to Strength, and Intention Setting for Healing. The resources in this book allow the reader to get actively involved in the healing journey, thus making it a companion guide for an individual desiring to change.

About the Author

Frank Rahmaan is a storyteller and an advocate who dedicates his efforts to reforming people’s lives from trauma to healing. From the ideology and form B shaped by Oakland’s culture, he gets his thoughts from life experiences and people’s challenges and adages to empower the reader on the journey that is self-discovery.

Outside the written word, Rahmaan loves spending time with his wife and their daughter, giving back to society, and taking part in creative activities that promote growth and connection.

Availability

The Wilted Black Rose: Breaking Free from Multi-Generational Trauma is available for purchase at major online retailers, including Amazon. Bulk orders for educational or promotional use can be arranged.

Media Contact
Company Name: The Empire Publishers (USA)
Contact Person: Frank Rahmaan
Email: Send Email
City: Katy
State: Texas
Country: United States
Website: https://www.theempirepublishers.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Breaking Free: Frank Rahmaan’s “The Wilted Black Rose” Explores Resilience and Redemption

Unleash Ultimate Potential: Quatrell’s “Cut From A Different Cloth” Inspires Readers to Break Barriers and Achieve Greatness

A Powerful Guide to Overcoming Adversity and Manifesting Your Dreams, “Cut From A Different Cloth” shares Quatrell’s inspiring journey from military service to entrepreneurial success, offering readers practical strategies and a powerful mindset shift to unlock their own limitless potential.

If you’ve ever felt trapped by expectations, stuck in a cycle of doubt, or unsure of how to take control of your destiny, Cut From A Different Cloth by Quatrell is the game-changing book you need.

Quatrell, with potent personal stories, time-tested wisdom, and practical frameworks, beckons readers along a road toward transformation to manifest their greatest potential and accept their own roads to success.

A Story of Resilience, Leadership, and Triumph

From the front lines of Iraq and Afghanistan to the back rooms of a successful enterprise, Quatrell’s life is the content of legends of endurance and self-mastery. To become a U.S. military veteran who served three distinguished tours—Operation Iraqi Freedom and Operation Enduring Freedom—adversity, coupled with stronger determination, his very own ordeal.

Quatrell’s transition from military life to the world of entrepreneurs has been hard yet has made him an ardent supporter of the view that it is strenuous indeed, but anyone can rise above their conditions if they have the right mindset and tools. As he says, “We are all cut from different cloth. Once we recognize our own strengths and step into our unique identities, we unlock limitless opportunities.”

What This Book Will Teach You

Cut From A Different Cloth is not just another self-help book; it is an act of empowerment. Quatrell dares to propose a new perspective on success and to share proven, real-life methods that can help break the shackles of mediocrity and start living authoritatively.

• How to Cultivate a Winning Mindset—Switch the mindset from limitation to possibility.

• A Blueprint to Long-Term Success—Setting realistic goals and breaking these down into actionable steps.

• Mastering the Art of Risk—Be bold and strategic in those calculated moves.

• Overcoming Doubt and Fear—Stop doubting yourself and build ironclad confidence.

• Power With Discipline and Adaptability—Being good at whatever with changing circumstances.

• Breaking Away from Norm—How to create your lane instead of following one.

From Soldier to Entrepreneur: A Masterclass in Reinvention

From early days as an entrepreneur in school, penning love letters for classmates, he has found opportunities while others found obstacles. In Cut From A Different Cloth, he teaches—mostly from his own experience—that turning setbacks into success for himself cannot be the end of the road for his audience.

He wants readers to see their challenges as a steppingstone. “The book is about rewriting your narrative. I want people to know that their past does not define their future. You are empowered at any time to change the telling of your story.“

A Book for Leaders, Dreamers, and Game-changers

Whether you are an aspiring entrepreneur, a professional pursuing a career, or someone seeking a greater sense of purpose, the book gives you the blueprint to set yourself free from limitations and design a life you love, a life in which you excel.

Who Should Read Cut From A Different Cloth?

• This is for aspiring as well as accomplished entrepreneurs who want strategies.

• For veterans stepping into civilian life.

• Professionals working on their personal and career growth.

• Anyone tired of letting life decide and is ready to take charge of their destiny.

A Movement, Not Just a Book

Cut From A Different Cloth is much more than the words on the pages of a book; it is a movement about being true to oneself, representing resilience, and embracing the pursuit of excellence. Through mentorships, leadership coaching, and public speaking, Quatrell expands his mission to help others see their potential and move toward greatness.

Where to Buy & How to Connect

The book is available now in stores and online. Inquiries regarding the book, interviewing the authors, or speaking engagements:

Quatrell Walker

(315) 965-3030

www.quatrellwalker.com

About the Author

Quatrell: Veteran, entrepreneur, speaker, and mentor devoted to uplifting people by reminding them of their worth and pursuing their dreams. Cut From A Different Cloth is an expression of his ardent conviction that success belongs to everyone, provided they reach out and claim it.

Join the Movement. Break the Mold. Live with Purpose.

Are you ready to define success and step into greatness? Get your copy of Cut From A Different Cloth today!

Media Contact
Company Name: The Empire Publishers (USA)
Contact Person: Quatrell Walker
Email: Send Email
City: Watertown
State: New York
Country: United States
Website: https://www.theempirepublishers.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Unleash Ultimate Potential: Quatrell’s “Cut From A Different Cloth” Inspires Readers to Break Barriers and Achieve Greatness

The Land of Paron: A Five-Book Fantasy Epic Where Heroes Rise and Legends Are Born

Dive into a world of epic fantasy where dragons soar, magic reigns, and heroes rise to meet their destiny. The Land of Paron series is a five-book saga that will captivate readers of all ages.

Embark on an extraordinary journey through “The Land of Paron,” a masterfully crafted five-book series that redefines the boundaries of epic fantasy. Rich with breathtaking landscapes, unforgettable characters, and riveting adventures, this saga will leave readers spellbound.

Five Stories, One Incredible World

Wander through the vast expanse of The Land of Paron, where the ancient prophecies, the mysterious creatures, and the timeless battle of good and evil will all come to light. Each title features its own exciting journey while it contributes to an epic narrative arc within the entire collection.

• “Valkomert the White”: Deep inside the Shadow Mountains, the dwarves are digging with their pickaxes into the strange ore Thombilite and awaken the mightiest dragon of all time: Valkomert. This is hardly the best preface before an explosive confrontation of mortals against an ancient power.

• “Gaventor’s Journey”: Follow the orphaned Gaventor as he learns of his abilities and becomes the most powerful wizard in the Land of Paron. With the help of others Gaventor fights to end the evil sorcerer Rombithon’s quest to control and destroy the land.

• “Beyond the Shadow Lands”: Dommilon Greystar and Biligius Hammerstrike begin their journey through the treacherous Shadow Lands, battling against fiercer beasts, hidden ages, and their freedom.

• “Marauders of the Anlomez”: Plummeted into depths of perilous waters, pirates, and privateers depleted the balance of survival with Captain Fermiston of the Madame Louina who must outwit those ruthless marauders while preserving precious cargo bound from the mines of Minsentus. Intrigue on the High Seas as ferocious sea and land creatures force those who sail the Anlomez Ocean to fight for their lives

• “Mystic’s Scroll”: Gaventor finds a scroll of awesome might in the heart of a dragon’s lair, which will speed him into an adventure against time in opening secrets penned to the greatest mystical beings that ever shaped Paron’s destiny.

The Land of Paron’s Unseen Wonders

The series stands out for its intricate world-building and vividly portrayed landscapes. From the towering Shadow Mountains to the treacherous Anlomez Ocean, each set scene looms large and grows into something that can be fully understood and trusted.

• Intricate Lore: The series features legends and histories that lend unparalleled depth to its narrative.

• Diverse Cultures: Elves, dwarves, wizards, dragons, and even shadowy brigands carry unique heritage and stories.

• Magical Realism: Paron blends mysticism with realism, making it a world that feels both fantastical and lived-in.

Themes That Resonate: Courage, Unity, and Hope

Like true works of art, The Land of Paron is a perfect example of time-honored themes that will echo in the hearts and souls of all generations of readers. The series, among many, fits the following descriptions:

• The Power of Unity: Many different heroes come together to face a common threat.

• Resilience in Adversity: Each challenge a hero has to complete tests his strength and spirit.

• The Triumph of Light: The main theme of the saga is the constant battle between good and evil.

What Readers Are Saying

This series has been absolutely acclaimed by audiences and critics alike, not necessarily for excellent narratives but for a rich, imaginative world:

“A breathtaking blend of action, emotion, and wonder. This series is fantasy at its best..” – Fantasy Today.

“Kennett’s prodigious storytelling creates a world so brilliant and lively that only a Tolkien would admit its visages into his middle-earth.” – Readers’ Retreat.

“One epic that will have readers turning pages deep into the night. The Land of Paron is unforgettable.” – Imagination Quarterly.

Behind the Scenes: Imaginative Mind of L Denton Kennett

L Denton Kennett, the creative head behind “The Land of Paron,” creates works upon the great classics of fantasy but with his own unique voice. He illuminates the world with multi-dimensional characters he has always enjoyed so much writing against immersive worlds, inviting readers into a saga that will linger for ages after the last page.

A Series Made for Adventure Seekers

Whether you’re a lifelong fan of fantasy or a newbie to this genre, “The Land of Paron” has something for everyone:

• Massive-engaged battle fans will enjoy the furious collision of dragon versus wizard versus warrior.

• Great historians will find paradise in the dense histories of Paron.

• Emotionalists will dive into the personal lives of the heroes with all the good and the evil.

Available Now: Begin Your Adventure Today

Don’t wait to experience this extraordinary saga. The “Land of Paron” series is available now:

• Valkomert the White of the Shadow Mountains: Here

• Gaventor’s Journey to the Second Land of Paron: Here

• Marauders of the Anlomez: Book Four of Paron: Here

• Mystic’s Scroll: The Fifth Land of Paron: Here

• Beyond the Shadow Lands: The Third Land of Paron: Here

Media Contact
Company Name: The Empire Publishers (USA)
Contact Person: Larry Denton Kennett
Email: Send Email
Country: United States
Website: https://www.theempirepublishers.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: The Land of Paron: A Five-Book Fantasy Epic Where Heroes Rise and Legends Are Born

Softek Awnings of Atlanta Launches a Cutting-Edge Website – Redefining Custom Shade Solutions

“Commercial Awnings Installation in Atlanta by Softek Awnings”

Imagine transforming your property into a visual masterpiece — a bold statement that marries practical protection with irresistible style.

Today, Softek Awnings, the trusted Custom Shade Solution Provider and Awning supplier in Atlanta, is proud to announce the launch of its brand-new website, opening the door to a realm of custom shading solutions crafted exclusively for you.

This isn’t just another website update – it’s an invitation to experience the secret behind truly captivating awnings. For years, Softek Awnings has turned ordinary spaces into landmarks, gracing renowned locations such as Hartsfield-Jackson International Airport, Phipps Plaza, and Emory University. Now, under the visionary leadership of Barry Loudis and Blackwing Advisors, we are set to redefine what custom awning design can achieve.

The new digital home is designed with a singular purpose: to showcase the craftsmanship and ingenuity behind every bespoke creation. Whether you’re a commercial store or building owner looking to elevate your brand’s appeal or a homeowner seeking both beauty and utility, our custom awnings not only fend off harsh UV rays and lower energy costs but also transform everyday spaces into extraordinary experiences.

Serving the Atlanta and metro area with unmatched expertise, Softek Awnings offers an extensive suite of services designed to elevate both commercial and residential properties. Our comprehensive portfolio includes commercial and residential awnings, outdoor curtains, canopies, window awnings, sun shades, shade structures, retractable awnings, pergolas, patio covers, and specialized awnings for patios. Each solution is meticulously engineered to combine beauty with functionality, ensuring your property not only stands out but also enjoys lasting protection against the elements. Whether you’re enhancing a bustling storefront or a serene home retreat, our innovative designs and dedicated craftsmanship meet the diverse needs of Atlanta’s dynamic climate.

Visit our new website, complete the simple contact form, and unlock the potential of a space that’s as unique as you are. This is your chance to embrace a fusion of art and engineering that only Softek Awnings can deliver.

Media Contact
Company Name: Softek Awnings
Contact Person: Barry Loudis
Email: Send Email
Phone: (678) 904-5637
Address:3641 Clearview Parkway
City: Doraville
State: Georgia
Country: United States
Website: https://softekawnings.com

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Softek Awnings of Atlanta Launches a Cutting-Edge Website – Redefining Custom Shade Solutions

The Benitez Team & NEXA Mortgage: Transforming Central Florida’s Homebuying Experience with Unprecedented Success

“William Benitez (The Benitez Team) & Idaris Morales (NEXA Mortgage)”

Orlando, FL – Just months after launching their innovative real estate and mortgage partnership, The Benitez Team and NEXA Mortgage have already made a significant impact on Central Florida’s homebuying market.

This seamless, all-in-one approach has helped countless buyers secure homes faster and with greater ease, proving to be a game-changer for local residents.

With over 30 years of industry expertise, The Benitez Team’s unique model—combining real estate and mortgage services under one roof—has drastically reduced closing times, simplified financing, and eliminated traditional roadblocks in the homebuying process. Homebuyers across Central Florida are now experiencing a faster, more efficient path to homeownership.

A Proven Solution for Homebuyers

The success of this model is evident in the growing number of satisfied homeowners. By offering direct access to mortgage approvals and real estate experts in one place, The Benitez Team has streamlined the process, allowing buyers to move into their dream homes without delays or unnecessary stress.

“Our mission was to simplify homeownership, and the results speak for themselves,” said William Benitez, President of The Benitez Team. “We’ve helped so many families secure their homes faster, with better financial options and a stress-free experience.”

Why This Model is Thriving

• Homebuyers closing on properties in record time

• Increased access to competitive mortgage rates

• Seamless, coordinated service between loan officers and realtors

• Unmatched expertise guiding buyers every step of the way

Making a Lasting Impact in Central Florida

The overwhelming success of this approach has positioned The Benitez Team as a leader in Central Florida’s real estate market. First-time buyers, families upgrading, and investors alike are benefiting from the efficiency and convenience this model provides.

For those looking to take advantage of this revolutionary homebuying experience, The Benitez Team is ready to help make homeownership easier and faster than ever before.

About The Benitez Team

The Benitez Team, in partnership with NEXA Mortgage, has over 30 years of industry experience. Their all-in-one real estate and mortgage solution is redefining homebuying in Central Florida with faster approvals and a stress-free process.

Media Contact:

The Benitez Team

Website: https://www.williambenitez.com

Phone Number: 787-630-8560

Email: williambenitez1@gmail.com

Media Contact
Company Name: The Benitez Team
Contact Person: William Benitez
Email: Send Email
Phone: 787-630-8560
Address:1392 Narcoossee Rd
City: Saint Cloud
State: FL
Country: United States
Website: https://www.williambenitez.com

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: The Benitez Team & NEXA Mortgage: Transforming Central Florida’s Homebuying Experience with Unprecedented Success

Chronic Pulmonary Hypertension Market Expected to rise, 2034 | COMPASS Pathways, Homeostasis Therapeutics, LLC, expected to drive market

“Chronic Pulmonary Hypertension market growth”

The Chronic Pulmonary Hypertension market growth is driven by factors like increase in the prevalence of Chronic Pulmonary Hypertension, investments in research and development, entry of emerging therapies during the study period 2020-2034.

The Chronic Pulmonary Hypertension market report also offers comprehensive insights into the Chronic Pulmonary Hypertension market size, share, Chronic Pulmonary Hypertension epidemiology, emerging therapies, market drivers and barriers, ongoing clinical trials, key collaboration in the space, market uptake by key therapies and companies actively pushing Chronic Pulmonary Hypertension market size growth forward.

Some of the key highlights from the Chronic Pulmonary Hypertension Market Insights Report:

Several key pharmaceutical companies, including COMPASS Pathways, Homeostasis Therapeutics, LLC, and others, are developing novel products to improve the Chronic Pulmonary Hypertension treatment outlook.
In January 2025, AliveGen USA Inc. (AliveGen), a clinical-stage biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to ALG-801 for treating pulmonary arterial hypertension (PAH), a rare and life-threatening condition characterized by high blood pressure in the lung arteries, which can lead to right-sided heart failure.
In December 2024, Nicox announced that its Denali Phase III trial, assessing the efficacy and safety of NCX470 for patients with open-angle glaucoma or ocular hypertension, has completed enrollment in China, and screening has concluded.
In November 2024, MediPrint Ophthalmics revealed the results of its Phase IIb clinical trial for LL-BMT1. The trial utilized a new 3D-printed, drug-eluting contact lens for continuous delivery of bimatoprost and hyaluronic acid, successfully meeting all the Phase IIb endpoints.
The prevalence of chronic pulmonary hypertension is expected to rise due to factors such as aging populations, increasing obesity rates, better survival rates among premature infants, environmental influences, genetic factors, improved diagnostics, and a rise in comorbidities.
In 2023, the US represented the largest share of diagnosed chronic pulmonary hypertension patients in the 7MM, with 42%, followed by Japan, which accounted for around 16% of cases. Among European countries, the UK had the highest number of cases, representing approximately 11% of the total 7MM cases.
In 2023, the chronic pulmonary hypertension market was the largest in the US, with a market size of about USD 15,700 million, a figure expected to grow by 2034.
Despite the high prevalence, with around 42,476 thousand cases in the 7MM in 2023, the market for chronic pulmonary hypertension treatment remains limited, with few therapies specifically targeting the condition. However, emerging therapies could significantly impact the market, potentially driving substantial growth.
As per DelveInsight analysis, the Chronic Pulmonary Hypertension market is anticipated to witness growth at a considerable CAGR

Strategise your business goals by understanding market dynamics @ Chronic Pulmonary Hypertension Market Landscape

Chronic Pulmonary Hypertension Overview

Chronic pulmonary hypertension is a condition characterized by high blood pressure in the lungs, which places strain on the heart and can lead to severe symptoms like shortness of breath and fatigue. It is classified into five groups: Group 1 includes pulmonary arterial hypertension (PAH), Group 2 is pulmonary hypertension caused by left heart disease, Group 3 is pulmonary hypertension linked to lung diseases and/or hypoxia, Group 4 refers to chronic thromboembolic pulmonary hypertension (CTEPH), and Group 5 encompasses pulmonary hypertension with unknown or multifactorial causes. Early detection and proper treatment are essential to improve outcomes and quality of life. Diagnosing chronic pulmonary hypertension involves a combination of clinical assessment, imaging, and specialized tests. Challenges can arise due to the nonspecific nature of the symptoms and the need to differentiate pulmonary hypertension from other cardiovascular and respiratory conditions. Diagnostic methods include echocardiography to evaluate heart function and estimate pulmonary artery pressure, followed by confirmatory tests like right heart catheterization, which directly measures pulmonary artery pressures. Accurate interpretation of results can be challenging, especially in cases where other heart or lung conditions are present, requiring a thorough differential diagnosis.

Do you know the treatment paradigms for different countries? Download our Chronic Pulmonary Hypertension Market Sample Report

Chronic Pulmonary Hypertension Epidemiology Insights

The number of chronic pulmonary hypertension cases in the US is projected to grow at a significant compound annual growth rate (CAGR) by 2034, starting from approximately 17,910 thousand cases in 2023.
In Europe, Germany had the highest prevalence of chronic pulmonary hypertension, accounting for 26% of cases, followed by the UK in 2023. Conversely, Spain had the lowest prevalence, with around 15% of the total diagnosed cases of chronic pulmonary hypertension in the same year.

Chronic Pulmonary Hypertension Epidemiology Segmentation

DelveInsight’s Chronic Pulmonary Hypertension market report is prepared on the basis of epidemiology model. It offers comprehensive insights to the Chronic Pulmonary Hypertension historical patient pools and forecasted Chronic Pulmonary Hypertension patients. The report provides in-depth data of various subtypes and for the same epidemiology is segmented further. The Chronic Pulmonary Hypertension Market report proffers epidemiological analysis for the study period 2020-34 in the 7MM segmented into:

Chronic Pulmonary Hypertension Prevalence
Age-Specific Chronic Pulmonary Hypertension Prevalence
Gender-Specific Chronic Pulmonary Hypertension Prevalence
Diagnosed and Treatable Cases of Chronic Pulmonary Hypertension

Visit for more @ Chronic Pulmonary Hypertension Epidemiological Insights

Chronic Pulmonary Hypertension Market Outlook

Phosphodiesterase-5 (PDE-5) inhibitors like Sildenafil and Tadalafil help reduce vascular smooth muscle cell proliferation and promote vasodilation. Endothelin receptor antagonists, including Ambrisentan, Bosentan, and Macitentan, counteract vasoconstriction and smooth muscle cell growth in the pulmonary arteries. Commonly used calcium channel blockers, such as Nifedipine, diltiazem, and amlodipine, are recommended for treating Pulmonary Arterial Hypertension (PAH). Prostacyclins like epoprostenol, treprostinil, and iloprost improve functional capacity and survival in PAH patients.

Additionally, IP prostacyclin receptor agonists, which activate the prostacyclin pathway, are also used for chronic pulmonary hypertension (PH). Endothelin receptor antagonists reduce endothelin-1 levels, which cause constriction and changes in the pulmonary blood vessels in PAH patients.

PDE-5 inhibitors and soluble guanylate cyclase (sGC) stimulators help lower enzyme levels that produce nitric oxide (NO), a substance that relaxes pulmonary blood vessels. By increasing cyclic GMP levels, these drugs promote vasodilation. PDE-5 inhibitors prevent the breakdown of cyclic GMP, while sGC stimulators enhance cyclic GMP production when NO binds to the sGC enzyme, making them effective treatments for PAH.

Chronic Pulmonary Hypertension Marketed Drugs

ADEMPAS (riociguat): Bayer

Chronic Pulmonary Hypertension Emerging Drugs

CS1: Cereno Scientific AB

Chronic Pulmonary Hypertension Key Companies

COMPASS Pathways, Homeostasis Therapeutics, LLC, and others

For more information, visit Chronic Pulmonary Hypertension Market Analysis, Patient Pool, and Emerging Therapies

Scope of the Chronic Pulmonary Hypertension Market Report:

11 Years Forecast
7MM Coverage
Descriptive overview of Chronic Pulmonary Hypertension, causes, signs and symptoms, diagnosis, treatment
Comprehensive insight into Chronic Pulmonary Hypertension epidemiology in the 7MM
Chronic Pulmonary Hypertension marketed and emerging therapies
Chronic Pulmonary Hypertension companies
Chronic Pulmonary Hypertension market drivers and barriers

Table of Contents:

1 Chronic Pulmonary Hypertension Market Key Comprehensive Insights

2 Chronic Pulmonary Hypertension Market Report Introduction

3 Competitive Intelligence Analysis for Chronic Pulmonary Hypertension

4 Chronic Pulmonary Hypertension Market Analysis Overview at a Glance

5 Executive Summary of Chronic Pulmonary Hypertension

6 Chronic Pulmonary Hypertension Epidemiology and Market Methodology

7 Chronic Pulmonary Hypertension Epidemiology and Patient Population

8 Chronic Pulmonary Hypertension Patient Journey

9 Chronic Pulmonary Hypertension Treatment Algorithm, Chronic Pulmonary Hypertension Current Treatment, and Medical Practices

10 Key Endpoints in Chronic Pulmonary Hypertension Clinical Trials

11 Chronic Pulmonary Hypertension Marketed Therapies

12 Chronic Pulmonary Hypertension Emerging Therapies

13 Chronic Pulmonary Hypertension: 7 Major Market Analysis

14 Attribute analysis

15 Access and Reimbursement Overview of Chronic Pulmonary Hypertension

16 Chronic Pulmonary Hypertension Market Key Opinion Leaders Reviews

18 Chronic Pulmonary Hypertension Market Drivers

19 Chronic Pulmonary Hypertension Market Barriers

20 SWOT Analysis

21 Disclaimer

22 DelveInsight Capabilities

23 About DelveInsight

Related Reports:

Chronic Pulmonary Hypertension Epidemiology 2034

DelveInsight’s “Chronic Pulmonary Hypertension – Epidemiology Forecast to 2034” report delivers an in-depth understanding of the disease, historical and forecasted Chronic Pulmonary Hypertension epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Chronic Pulmonary Hypertension Pipeline 2024

“Chronic Pulmonary Hypertension Pipeline Insights, 2024” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Chronic Pulmonary Hypertension market. A detailed picture of the Chronic Pulmonary Hypertension pipeline landscape is provided, which includes the disease overview and Chronic Pulmonary Hypertension treatment guidelines.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Chronic Pulmonary Hypertension Market Expected to rise, 2034 | COMPASS Pathways, Homeostasis Therapeutics, LLC, expected to drive market

Guiding Souls Home Care Brings Fijian Excellence to Sacramento Senior Care

Delivering personalized in-home senior care with a legacy of trust and exceptional service.

Sacramento, CA – Guiding Souls Home Care proudly announces its mission to provide unparalleled in-home senior care in Sacramento, CA. With a reputation for exceptional caregiving rooted in Fijian values, the agency continues to meet the growing demand for compassionate and personalized care among Sacramento’s senior community.

“Mereani Blanton, owner of Guiding Souls Home Care, shared, “At Guiding Souls Home Care, we believe in more than providing care; we build trust and nurture connections. Our Fijian caregivers are celebrated for their genuine compassion and dedication, and this trust leads families to choose us time and again. By bringing our cultural values to Sacramento senior care, we ensure everyone feels respected, supported, and at home in their golden years.”

The agency takes immense pride in its team of caregivers, most of whom come from Fijian backgrounds and are renowned for their warm, nurturing approach to care. Many clients specifically request Fijian caregivers due to the trust and exceptional service they provide. This cultural touch not only enhances the quality of care but also fosters a deep sense of connection between caregivers and families. This blend of professionalism and heartfelt service sets Guiding Souls apart.

With seniors representing one of the fastest-growing populations in Sacramento, the demand for reliable, in-home senior care is more critical than ever. Guiding Souls Home Care recognizes the importance of keeping seniors in familiar surroundings where they can retain their independence and dignity. A caregiver who genuinely understands their needs ensures seniors feel supported, safe, and valued in every aspect of their daily lives.

Home care services are essential for promoting the well-being of seniors who face challenges such as mobility issues, chronic conditions, or memory loss. Guiding Souls Home Care offers families peace of mind, knowing their loved ones are in capable and caring hands. From assisting with day-to-day activities to providing emotional and social support, their services are tailored to improve seniors’ overall quality of life.

The need for high-quality senior care in Sacramento is rising, with many families seeking reliable caregivers who prioritize their loved one’s dignity and independence. Guiding Souls Home Care stands out through its personalized services tailored to each client’s unique needs, ranging from daily assistance to comprehensive health support. Fijian caregivers, known for their warmth and attentiveness, have become an integral part of this exceptional care model, often requested by clients who have experienced their service firsthand.

Families looking for trustworthy Sacramento senior care can rely on Guiding Souls Home Care to provide their loved ones with a higher quality of life. For more information about Guiding Souls Home Care and their in-home senior care in Sacramento, CA, please visit their website at https://guidingsoulshomecare.com.

About Guiding Souls Home Care:

Guiding Souls Home Care is a premier provider of in-home senior care services in Sacramento, CA. Founded on Fijian values of respect, compassion, and family, the agency offers tailored care solutions designed to meet the diverse needs of seniors. With a dedicated team of caregivers, Guiding Souls Home Care aims to enhance the well-being of its clients, allowing them to thrive in the comfort of their homes.

Media Contact
Company Name: Guiding Souls Home Care
Contact Person: Mereani Blanton
Email: Send Email
Phone: +1 877 671 5692
Address:3626 Fair Oaks Blvd Suite 100B
City: Sacramento
State: CA, 95864
Country: United States
Website: guidingsoulshomecare.com

Periodontal Disease Market Expected to rise, 2032 | Dentsply Sirona Inc., Envista Holdings Corporation, A-dec Inc., J. Morita Corp., Straumann Group, BIOLASE, BEGO GmbH & Co. KG, Ultradent Products, Y

“Periodontal Disease Market 2032”

The Periodontal Disease market growth is driven by factors like increase in the prevalence of Periodontal Disease, investments in research and development, entry of emerging therapies during the study period 2019-2032.

The Periodontal Disease market report also offers comprehensive insights into the Periodontal Disease market size, share, Periodontal Disease epidemiology, emerging therapies, market drivers and barriers, ongoing clinical trials, key collaboration in the space, market uptake by key therapies and companies actively pushing Periodontal Disease market size growth forward.

Some of the key highlights from the Periodontal Disease Market Insights Report:

Several key pharmaceutical companies, including Dentsply Sirona Inc., Envista Holdings Corporation, A-dec Inc., J. Morita Corp., Straumann Group, BIOLASE, BEGO GmbH & Co. KG, Ultradent Products, Yoshida Dental, and others, are developing novel products to improve the Periodontal Disease treatment outlook.
In August 2021, the NIH granted $2 million to the ADA Science & Research Institute and the University of Pennsylvania to explore oral mucosa. This collaboration will focus on understanding the mechanisms that preserve and damage the oral epithelium’s barrier function in the context of periodontal disease and peri-implantitis.
In July 2021, Cortexyme shared new preclinical data at the International Association for Dental Research (IADR) 2021 General Session & Exhibition, a virtual event, highlighting the effective dose range for its leading drug candidate, atuzaginstat (COR388), in treating periodontal disease.
As per DelveInsight analysis, the Periodontal Disease market is anticipated to witness growth at a considerable CAGR

Strategise your business goals by understanding market dynamics @ Periodontal Disease Market Landscape

Periodontal Disease Overview

Periodontal disease, also called gum disease, is a collection of inflammatory conditions that affect the tissues surrounding and supporting the teeth. It begins with bacterial growth in the mouth, which leads to plaque buildup on the teeth. If plaque is not properly removed through regular oral hygiene, it can harden into tartar, resulting in gum inflammation (gingivitis) and potentially advancing to more serious stages of periodontal disease.

The main cause of periodontal disease is the buildup of bacteria in the form of plaque on the teeth. Key risk factors include poor oral hygiene, smoking, hormonal changes, certain medications, genetic factors, underlying health issues (like diabetes), and a weakened immune system.

Do you know the treatment paradigms for different countries? Download our Periodontal Disease Market Sample Report

Periodontal Disease Epidemiology Segmentation

DelveInsight’s Periodontal Disease market report is prepared on the basis of epidemiology model. It offers comprehensive insights to the Periodontal Disease historical patient pools and forecasted Periodontal Disease patients. The report provides in-depth data of various subtypes and for the same epidemiology is segmented further. The Periodontal Disease Market report proffers epidemiological analysis for the study period 2019-32 in the 7MM segmented into:

Periodontal Disease Prevalence
Age-Specific Periodontal Disease Prevalence
Gender-Specific Periodontal Disease Prevalence
Diagnosed and Treatable Cases of Periodontal Disease

Visit for more @ Periodontal Disease Epidemiological Insights

Periodontal Disease Market Outlook

The periodontal disease treatment market is poised for substantial growth, driven by increasing awareness of oral health, technological advancements, and a rising geriatric population more susceptible to dental issues. However, addressing challenges such as high treatment costs and the shortage of skilled professionals will be crucial for sustaining this growth trajectory.

Periodontal Disease Key Companies

Dentsply Sirona Inc., Envista Holdings Corporation, A-dec Inc., J. Morita Corp., Straumann Group, BIOLASE, BEGO GmbH & Co. KG, Ultradent Products, Yoshida Dental, and others

For more information, visit Periodontal Disease Market Analysis, Patient Pool, and Emerging Therapies

Scope of the Periodontal Disease Market Report:

11 Years Forecast
7MM Coverage
Descriptive overview of Periodontal Disease, causes, signs and symptoms, diagnosis, treatment
Comprehensive insight into Periodontal Disease epidemiology in the 7MM
Periodontal Disease marketed and emerging therapies
Periodontal Disease companies
Periodontal Disease market drivers and barriers

Table of Contents:

1 Periodontal Disease Market Key Comprehensive Insights

2 Periodontal Disease Market Report Introduction

3 Competitive Intelligence Analysis for Periodontal Disease

4 Periodontal Disease Market Analysis Overview at a Glance

5 Executive Summary of Periodontal Disease

6 Periodontal Disease Epidemiology and Market Methodology

7 Periodontal Disease Epidemiology and Patient Population

8 Periodontal Disease Patient Journey

9 Periodontal Disease Treatment Algorithm, Periodontal Disease Current Treatment, and Medical Practices

10 Key Endpoints in Periodontal Disease Clinical Trials

11 Periodontal Disease Marketed Therapies

12 Periodontal Disease Emerging Therapies

13 Periodontal Disease: 7 Major Market Analysis

14 Attribute analysis

15 Access and Reimbursement Overview of Periodontal Disease

16 Periodontal Disease Market Key Opinion Leaders Reviews

18 Periodontal Disease Market Drivers

19 Periodontal Disease Market Barriers

20 SWOT Analysis

21 Disclaimer

22 DelveInsight Capabilities

23 About DelveInsight

Related Reports:

Periodontal Disease Epidemiology 2032

DelveInsight’s “Periodontal Disease – Epidemiology Forecast to 2032” report delivers an in-depth understanding of the disease, historical and forecasted Periodontal Disease epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Periodontal Disease Pipeline 2024

“Periodontal Disease Pipeline Insights, 2024” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Periodontal Disease market. A detailed picture of the Periodontal Disease pipeline landscape is provided, which includes the disease overview and Periodontal Disease treatment guidelines.

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Periodontal Disease Market Expected to rise, 2032 | Dentsply Sirona Inc., Envista Holdings Corporation, A-dec Inc., J. Morita Corp., Straumann Group, BIOLASE, BEGO GmbH & Co. KG, Ultradent Products, Y

Chronic Lower Back Pain Market Expected to rise, 2034 | Eli Lilly and Company, Collegium Pharmaceutical, Purdue Pharma LP, BioDelivery Sciences International, Camurus, Braeburn Inc., Scilex Holding

“Chronic Lower Back Pain market growth”

The Chronic Lower Back Pain market growth is driven by factors like increase in the prevalence of Chronic Lower Back Pain, investments in research and development, entry of emerging therapies during the study period 2020-2034.

The Chronic Lower Back Pain market report also offers comprehensive insights into the Chronic Lower Back Pain market size, share, Chronic Lower Back Pain epidemiology, emerging therapies, market drivers and barriers, ongoing clinical trials, key collaboration in the space, market uptake by key therapies and companies actively pushing Chronic Lower Back Pain market size growth forward.

Some of the key highlights from the Chronic Lower Back Pain Market Insights Report:

Several key pharmaceutical companies, including Eli Lilly and Company, Collegium Pharmaceutical, Purdue Pharma LP, BioDelivery Sciences International, Camurus, Braeburn Inc., Scilex Holding, Mesoblast Limited, AnGes MG, Inc., Kolon Life Science, Eliem Therapeutics, Allodynic Therapeutics, Sollis Therapeutics, Medtronic Spinal and Biologics, Frontier Biotechnologies, DiscGenics Inc., Pfizer, Persica Pharmaceuticals, BioRestorative Therapies, Vertanical GmbH, Stayble Therapeutics, SpineThera, and others, are developing novel products to improve the Chronic Lower Back Pain treatment outlook.
In January 2025, Pacira BioSciences, Inc. secured FDA clearance for its Smart Tip, designed to target medial branch nerves for chronic low back pain management. The ioveraº system provides a drug-free approach, utilizing cryoneurolysis to deliver cold therapy, temporarily disrupting pain signals.
Chronic Lower Back Pain (CLBP) lasts 12+ weeks, even after the initial cause resolves. It’s a common issue affecting millions.
In 2023, the U.S. led the 7MM CLBP market at ~$4.2B, projected to grow at a 4% CAGR. Opioids like Xtampza ER & BELBUCA dominated treatment, making up ~$2.96B of the market.
Despite ~68M diagnosed cases, no CLBP-specific approved therapies exist. The market is driven by aging, sedentary lifestyles & new treatments.
Scilex’s SP-102 (SEMDEXA), a non-opioid injection for sciatica, may reshape the CLBP landscape upon its expected 2025 U.S. launch.
As per DelveInsight analysis, the Chronic Lower Back Pain market is anticipated to witness growth at a considerable CAGR

Strategise your business goals by understanding market dynamics @ Chronic Lower Back Pain Market Landscape

Chronic Lower Back Pain Overview

Chronic low back pain (CLBP) lasts 12+ weeks, even after the initial injury or cause has healed. It’s a widespread condition that most people experience at some point. The exact cause remains unclear, but when back pain persists for over three months, it’s classified as CLBP. As the second leading cause of disability worldwide, CLBP poses a major economic and social challenge. Its prevalence has surged in recent years, especially among aging populations. Beyond physical discomfort, CLBP has psychological impacts and contributes to lost productivity, high treatment costs, and disability-related expenses. #Healthcare #CLBP

Do you know the treatment paradigms for different countries? Download our Chronic Lower Back Pain Market Sample Report

Chronic Lower Back Pain Epidemiology Insights

In 2023, the U.S. had approximately 31 million diagnosed cases of CLBP, making up about 45% of the 7MM population. The EU4 and the UK together accounted for 40%, while Japan contributed 15%. Among the EU4, Spain had the highest CLBP prevalence (8.6M cases), followed by Germany (6.3M), while France reported the lowest (5M).

Chronic Lower Back Pain Epidemiology Segmentation

DelveInsight’s Chronic Lower Back Pain market report is prepared on the basis of epidemiology model. It offers comprehensive insights to the Chronic Lower Back Pain historical patient pools and forecasted Chronic Lower Back Pain patients. The report provides in-depth data of various subtypes and for the same epidemiology is segmented further. The Chronic Lower Back Pain Market report proffers epidemiological analysis for the study period 2020-34 in the 7MM segmented into:

Chronic Lower Back Pain Prevalence
Age-Specific Chronic Lower Back Pain Prevalence
Gender-Specific Chronic Lower Back Pain Prevalence
Diagnosed and Treatable Cases of Chronic Lower Back Pain

Visit for more @ Chronic Lower Back Pain Epidemiological Insights

Chronic Lower Back Pain Market Outlook

Chronic low back pain (CLBP) is a complex condition, much like how each patient experiences a unique disease progression. Consequently, treatment plans are highly individualized. Various classes of medications, each with a distinct mechanism of action, allow healthcare providers to target specific aspects of a patient’s pain. Additionally, patient-specific factors are carefully considered when designing a treatment regimen to enhance adherence and improve outcomes.

The majority (80–90%) of low back pain cases originate from mechanical causes, such as degenerative disc or joint disease, vertebral fractures, or structural deformities. Less commonly, neurogenic, inflammatory, and other etiologies contribute to the condition. Initial pharmacologic treatment should be based on the underlying cause; however, as pain becomes chronic, a broader, multimodal approach is often required due to the diminishing effectiveness of targeted therapies.

For inflammatory-related low back pain, treatment typically involves anti-inflammatory medications. This includes the early use of nonsteroidal anti-inflammatory drugs (NSAIDs) and, in cases of conditions like rheumatoid arthritis or ankylosing spondylitis, corticosteroids or disease-modifying antirheumatic drugs (DMARDs).

To effectively manage severe pain and improve patient quality of life, certain medications have received FDA approval for long-term, around-the-clock opioid treatment when alternative therapies are insufficient. These include Xtampza (Collegium Pharmaceutical) and BELBUCA (buprenorphine HCL buccal film; BioDelivery Sciences International).

Chronic Lower Back Pain Marketed Drugs

XTAMPZA ER (oxycodone): Collegium Pharmaceutical

Chronic Lower Back Pain Emerging Drugs

Rexlemestrocel-L (MPC-06-ID): Mesoblast Limited/Grünenthal
Semdexa (SP-102): Scilex Holding Company

Chronic Lower Back Pain Key Companies

Eli Lilly and Company, Collegium Pharmaceutical, Purdue Pharma LP, BioDelivery Sciences International, Camurus, Braeburn Inc., Scilex Holding, Mesoblast Limited, AnGes MG, Inc., Kolon Life Science, Eliem Therapeutics, Allodynic Therapeutics, Sollis Therapeutics, Medtronic Spinal and Biologics, Frontier Biotechnologies, DiscGenics Inc., Pfizer, Persica Pharmaceuticals, BioRestorative Therapies, Vertanical GmbH, Stayble Therapeutics, SpineThera, and others

For more information, visit Chronic Lower Back Pain Market Analysis, Patient Pool, and Emerging Therapies

Scope of the Chronic Lower Back Pain Market Report:

11 Years Forecast
7MM Coverage
Descriptive overview of Chronic Lower Back Pain, causes, signs and symptoms, diagnosis, treatment
Comprehensive insight into Chronic Lower Back Pain epidemiology in the 7MM
Chronic Lower Back Pain marketed and emerging therapies
Chronic Lower Back Pain companies
Chronic Lower Back Pain market drivers and barriers

Table of Contents:

1 Chronic Lower Back Pain Market Key Comprehensive Insights

2 Chronic Lower Back Pain Market Report Introduction

3 Competitive Intelligence Analysis for Chronic Lower Back Pain

4 Chronic Lower Back Pain Market Analysis Overview at a Glance

5 Executive Summary of Chronic Lower Back Pain

6 Chronic Lower Back Pain Epidemiology and Market Methodology

7 Chronic Lower Back Pain Epidemiology and Patient Population

8 Chronic Lower Back Pain Patient Journey

9 Chronic Lower Back Pain Treatment Algorithm, Chronic Lower Back Pain Current Treatment, and Medical Practices

10 Key Endpoints in Chronic Lower Back Pain Clinical Trials

11 Chronic Lower Back Pain Marketed Therapies

12 Chronic Lower Back Pain Emerging Therapies

13 Chronic Lower Back Pain: 7 Major Market Analysis

14 Attribute analysis

15 Access and Reimbursement Overview of Chronic Lower Back Pain

16 Chronic Lower Back Pain Market Key Opinion Leaders Reviews

18 Chronic Lower Back Pain Market Drivers

19 Chronic Lower Back Pain Market Barriers

20 SWOT Analysis

21 Disclaimer

22 DelveInsight Capabilities

23 About DelveInsight

Related Reports:

Chronic Lower Back Pain Epidemiology 2034

DelveInsight’s “Chronic Lower Back Pain – Epidemiology Forecast to 2034” report delivers an in-depth understanding of the disease, historical and forecasted Chronic Lower Back Pain epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Chronic Lower Back Pain Pipeline 2024

“Chronic Lower Back Pain Pipeline Insights, 2024” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Chronic Lower Back Pain market. A detailed picture of the Chronic Lower Back Pain pipeline landscape is provided, which includes the disease overview and Chronic Lower Back Pain treatment guidelines.

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Chronic Lower Back Pain Market Expected to rise, 2034 | Eli Lilly and Company, Collegium Pharmaceutical, Purdue Pharma LP, BioDelivery Sciences International, Camurus, Braeburn Inc., Scilex Holding